To evaluate the efficacy of Lactobacillus paracasei CNCM I-1572 (L. casei DG®) in both prevention of symptomatic recurrences and improvement of quality of life in patients with chronic bacterial prostatitis (CBP).
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study / Cai, Tommaso; Gallelli, Luca; Cione, Erika; Perletti, Gianpaolo; Ciarleglio, Francesco; Malossini, Gianni; De Pretis, Giovanni; Palmieri, Alessandro; Mirone, Vincenzo; Bartoletti, Riccardo; Johansen, Truls E Bjerklund. - In: WORLD JOURNAL OF UROLOGY. - ISSN 0724-4983. - (2021). [10.1007/s00345-020-03580-7]
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
Palmieri, Alessandro;Mirone, Vincenzo;
2021
Abstract
To evaluate the efficacy of Lactobacillus paracasei CNCM I-1572 (L. casei DG®) in both prevention of symptomatic recurrences and improvement of quality of life in patients with chronic bacterial prostatitis (CBP).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
